AgenDx Biosciences Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • (Upcoming)
  • Investors
  • 4

AgenDx Biosciences General Information

Description

Developer of a molecular diagnostics platform designed to offer healthcare professionals a wide range of nucleic-acid based testing. The company's platform helps in the expansion of the commercial viability of screening, diagnosing, treatment planning and monitoring, thus enabling healthcare professionals to offer better treatment and diagnostics for their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Diagnostic Equipment
Other Healthcare Technology Systems
Primary Office
  • 1400 East Angela Boulevard
  • Unit 126
  • South Bend, IN 46617
  • United States

AgenDx Biosciences Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AgenDx Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) Upcoming Generating Revenue
3. Seed Round 30-Jul-2019 00000 00.000 Completed Generating Revenue
2. Seed Round 23-Jan-2018 $675K $2.23M Completed Generating Revenue
1. Seed Round 15-Jan-2016 $1.56M $1.56M 00.000 Completed Generating Revenue
To view AgenDx Biosciences’s complete valuation and funding history, request access »

AgenDx Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00.00 00.00 00 00.00 00.00
To view AgenDx Biosciences’s complete cap table history, request access »

AgenDx Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a molecular diagnostics platform designed to offer healthcare professionals a wide range of nucleic-acid ba
Decision/Risk Analysis
South Bend, IN
00.000
000000 0

0000000

ng elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,
0000000000000
San Diego, CA
00 As of 0000
00.000
0.00 0000-00-00
00000000000 00.000

00000000

uis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure do
0000000000000 00000000
Richmond Hill, Canada
00 As of 0000
0000
00000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AgenDx Biosciences Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mindera Venture Capital-Backed San Diego, CA 00 00.000 00000000000 00.000
000000000 0000 000 Corporation Richmond Hill, Canada 00 0000 00000000 0000
000000000 Corporate Backed or Acquired Cambridge, MA 00 000 000000&0 000
000000 00000000000 Venture Capital-Backed Pleasanton, CA 000000000000
0000000 Private Equity-Backed Irvine, CA 000 00000 000000000 - 00000
You’re viewing 5 of 21 competitors. Get the full list »

AgenDx Biosciences Executive Team (4)

Name Title Board Seat Contact Info
Kevin Connors Co-Founder, Chief Executive Officer & Board Member
Chris Wynne Chief Financial Officer
George Spohrer Chief Operating Officer
Benjamin Miller Co-Founder
To view AgenDx Biosciences’s complete executive team members history, request access »

AgenDx Biosciences Board Members (1)

Name Representing Role Since
Kevin Connors AgenDx Biosciences Co-Founder, Chief Executive Officer & Board Member 000 0000
To view AgenDx Biosciences’s complete board members history, request access »

AgenDx Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
University Of Notre Dame USA In England University Minority 000 0000 000000 0
The Judd Leighton Foundation Limited Partner Minority 000 0000 000000 0
Vitalize Venture Group Venture Capital Minority 000 0000 000000 0
Elevate Ventures Venture Capital Minority 000 0000 000000 0
To view AgenDx Biosciences’s complete investors history, request access »